https://www.selleckchem.com/pr....oducts/BMS-790052.ht
To assess the differential response to neoadjuvant chemotherapy (NAC) in patients with urothelial carcinoma of the bladder (UC compared to upper tract urothelial carcioma (UTUC) treated with radical surgery. Data from 1299 patients with UCB and 276 with UTUC were obtained from multicentric collaborations. The association of disease location (UCB vs UTUC) with pathological complete response (pCR, defined as a post-treatment pathological stage ypT0N and pathological objective response (pOR, defined as ypT0-Ta-Tis-T1N after NAC wa
Like
Comment
Share
